Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)

Clinical trial NCT01504334 · UNKNOWN

Trial details

NCT number: NCT01504334
Sponsor: Beijing Kawin Technology Share-Holding Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2012-01-01
Primary completion: 2012-11-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.